中华放射学杂志
中華放射學雜誌
중화방사학잡지
Chinese Journal of Radiology
2014年
4期
311-315
,共5页
目的 探讨125I粒子食管支架治疗食管癌术后食管再狭窄的疗效与安全性.方法 收集60例本院就诊的食管癌术后食管再狭窄患者,采用随机数字分组法分为对照组和照射组,每组30例.对照组和照射组患者分别接受普通自膨式支架和125 I粒子自膨式支架植入治疗.术后计算支架植入成功率;术后1周和2个月对2组患者进行吞咽困难评分,判断食管狭窄改善情况;观察术后6个月2组患者的并发症;随访18个月,观察2组患者的生存情况.计量资料采用t检验进行比较,计数资料的比较行x2检验.结果 2组患者的支架均一次植入成功,成功率均为100%(30/30).术前吞咽困难评分,0、1、2、3、4分者对照组为分别为0、2、3、22和3例,照射组分别为0、2、2、23和3例;术后1周对照组上述评分分别为1、17、6、6和0例,照射组分别为4、21、3、2和0例,组间差异无统计学意义(P=0.675);术后2个月对照组上述评分的患者分别为25、3、2、0和0例,照射组分别为27、2、1、0和0例,组间差异也无统计学意义(x2=1.043,P=0.894).随访6个月,对照组出现消化道出血1例、疼痛4例、食管再狭窄8例,照射组出现上述并发症的患者分别为0、5和3例,照射组术后食管再狭窄发生率低于对照组,差异有统计学意义(x2=4.384,P=0.036).随访18个月.对照组30例患者中10例存活,20例死亡患者的生存期为2.0 ~ 14.0个月,平均(4.8±1.7)个月;照射组30例患者中15例存活,15例死亡患者的生存期为4.0~15.0个月,平均(9.8±2.9)个月,照射组患者的平均生存时间长于对照组,差异有统计学意义(t=8.917,P=0.002).结论 125I粒子支架在不增加并发症的同时能明显改善晚期食管癌患者食管狭窄症状和延长患者的生存期.
目的 探討125I粒子食管支架治療食管癌術後食管再狹窄的療效與安全性.方法 收集60例本院就診的食管癌術後食管再狹窄患者,採用隨機數字分組法分為對照組和照射組,每組30例.對照組和照射組患者分彆接受普通自膨式支架和125 I粒子自膨式支架植入治療.術後計算支架植入成功率;術後1週和2箇月對2組患者進行吞嚥睏難評分,判斷食管狹窄改善情況;觀察術後6箇月2組患者的併髮癥;隨訪18箇月,觀察2組患者的生存情況.計量資料採用t檢驗進行比較,計數資料的比較行x2檢驗.結果 2組患者的支架均一次植入成功,成功率均為100%(30/30).術前吞嚥睏難評分,0、1、2、3、4分者對照組為分彆為0、2、3、22和3例,照射組分彆為0、2、2、23和3例;術後1週對照組上述評分分彆為1、17、6、6和0例,照射組分彆為4、21、3、2和0例,組間差異無統計學意義(P=0.675);術後2箇月對照組上述評分的患者分彆為25、3、2、0和0例,照射組分彆為27、2、1、0和0例,組間差異也無統計學意義(x2=1.043,P=0.894).隨訪6箇月,對照組齣現消化道齣血1例、疼痛4例、食管再狹窄8例,照射組齣現上述併髮癥的患者分彆為0、5和3例,照射組術後食管再狹窄髮生率低于對照組,差異有統計學意義(x2=4.384,P=0.036).隨訪18箇月.對照組30例患者中10例存活,20例死亡患者的生存期為2.0 ~ 14.0箇月,平均(4.8±1.7)箇月;照射組30例患者中15例存活,15例死亡患者的生存期為4.0~15.0箇月,平均(9.8±2.9)箇月,照射組患者的平均生存時間長于對照組,差異有統計學意義(t=8.917,P=0.002).結論 125I粒子支架在不增加併髮癥的同時能明顯改善晚期食管癌患者食管狹窄癥狀和延長患者的生存期.
목적 탐토125I입자식관지가치료식관암술후식관재협착적료효여안전성.방법 수집60례본원취진적식관암술후식관재협착환자,채용수궤수자분조법분위대조조화조사조,매조30례.대조조화조사조환자분별접수보통자팽식지가화125 I입자자팽식지가식입치료.술후계산지가식입성공솔;술후1주화2개월대2조환자진행탄인곤난평분,판단식관협착개선정황;관찰술후6개월2조환자적병발증;수방18개월,관찰2조환자적생존정황.계량자료채용t검험진행비교,계수자료적비교행x2검험.결과 2조환자적지가균일차식입성공,성공솔균위100%(30/30).술전탄인곤난평분,0、1、2、3、4분자대조조위분별위0、2、3、22화3례,조사조분별위0、2、2、23화3례;술후1주대조조상술평분분별위1、17、6、6화0례,조사조분별위4、21、3、2화0례,조간차이무통계학의의(P=0.675);술후2개월대조조상술평분적환자분별위25、3、2、0화0례,조사조분별위27、2、1、0화0례,조간차이야무통계학의의(x2=1.043,P=0.894).수방6개월,대조조출현소화도출혈1례、동통4례、식관재협착8례,조사조출현상술병발증적환자분별위0、5화3례,조사조술후식관재협착발생솔저우대조조,차이유통계학의의(x2=4.384,P=0.036).수방18개월.대조조30례환자중10례존활,20례사망환자적생존기위2.0 ~ 14.0개월,평균(4.8±1.7)개월;조사조30례환자중15례존활,15례사망환자적생존기위4.0~15.0개월,평균(9.8±2.9)개월,조사조환자적평균생존시간장우대조조,차이유통계학의의(t=8.917,P=0.002).결론 125I입자지가재불증가병발증적동시능명현개선만기식관암환자식관협착증상화연장환자적생존기.
Objective To investigate clinical effect and safety of the 125I particle stent for treatment of postoperative esophageal stricture on patients with advanced esophageal cancer.Methods Sixty patients with postoperative esophageal stricture after esophageal cancer operation were randomly assigned to receive treatment with a conventional self-expanding stent (control group) or a stent loaded with 125I seeds (irradiation group).After stent implantation,the outcomes were compared in terms of the success rate of stent implantation,relief of dysphagia,survival time,and complications related to the procedure.Dysphagia was assigned a grade 0-4.The t test and the x2 test were used to make statistical analysis.Results The success rate of stents placement of two groups were 100% (30/30).The results of preoperative dysphagia score showed that the patients of control group with 0,1,2,3,4 degree were 0,2,3,22 and 3 patients ; the patients of radiation group with 0,1,2,3,4 degree were 0,2,2,23 and 3 patients; in postoperative 1 week,the control group turned to 1,17,6,6 and 0 patients,the radiation group turned to 4,21,3,2 and 0 patients ; the difference between the 2 groups was not statistically significant (x2 =1.214,P =0.675) ; in postoperative 2 months,the patients with the above degree of dysphagia score of control group were 25,3,2,0,0; and the radiation group were 27,2,1,0,0,the difference between the 2 groups was not statistically significant (x2 =1.043,P =0.894).Followed up for 6 months,1 patient gastrointestinal bleeding,4 patients gastrointestinal pain and 8 patients esophageal restenosis were occurred in control group,corresponding in irradiated group were 0,5,and 3 patients respectively,the incidence of postoperative esophageal restenosis of irradiated group was lower than control group,and the difference was statistically significant (x2 =4.384,P =0.036).After follow-up for 18 months,10 patients were survival among the 30 patients of control group,the live time of the 20 patients dead patients were 2 to 14 months,control group of 30 patients,10 patients of survival of 20 deaths of patients from 2 to 14 months,the average value was (4.8± 1.7)months ; there were 15 survival patients among irradiation group,the survival time of the 15 deaths was 4 to 15 months,and the average value was (9.8 ± 2.9) months.By the end of follow-up,the average survival time for all patients of irradiated group was longer than the control group,the difference was statistically significant (t =8.917,P =0.002).Conclusion In patients with postoperative esophageal stricture and advanced esophageal cancer,stent loaded with 125I stent has potential benefit in that it allows a longer relief of dysphagia and a longer survival time.